. (2008). Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?. J Intern Med. http://doi.org/10.1111/j.1365-2796.2008.01991.x
T. van Staa
First name
T.
Middle name
P.
Last name
van Staa
. (2008). Evaluating drug toxicity signals: is a hierarchical classification of evidence useful or a hindrance?. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.1568
. (2008). Fracture outcomes related to persistence and compliance with oral bisphosphonates. J Bone Miner Res. http://doi.org/10.1359/jbmr.080510
. (2008). Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?. J Thromb Haemost. http://doi.org/10.1111/j.1538-7836.2008.03059.x
. (2008). Individualizing the risks and benefits of postmenopausal hormone therapy. Menopause. http://doi.org/10.1097/gme.0b013e31812e558f
. (2008). What is the harm-benefit ratio of Cox-2 inhibitors?. Int J Epidemiol. http://doi.org/10.1093/ije/dym296
. (2009). The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates. Qjm. http://doi.org/10.1093/qjmed/hcn130
. (2009). Study of adverse outcomes in women using testosterone therapy. Maturitas. http://doi.org/10.1016/j.maturitas.2008.11.001
. (2009). Utilization characteristics and treatment persistence in patients prescribed low-dose buprenorphine patches in primary care in the United Kingdom: a retrospective cohort study. Clin Ther. http://doi.org/10.1016/j.clinthera.2009.08.022
. (2008). Changes in the characteristics of patients prescribed selective cyclooxygenase 2 inhibitors after the 2004 withdrawal of rofecoxib. Arthritis Rheum. http://doi.org/10.1002/art.23925